Here are five details:
1. For the first half of 2018, the company’s sales are up 22 percent at $19.77 million.
2. In the second quarter of 2018, Medicrea reported about $10.30 million in sales, up from first quarter 2018 sales of $9.59 million.
3. In June, Medicrea raked in $3.98 million in sales, its best month to date.
4. Medicrea recorded 116 patient-specific UNiD Rod surgeries performed in June. Since the technology launched, 2,500 surgeries have used the patient-specific rods.
5. Sales with international distributors grew 40 percent during the first half of 2018. In France, Medicrea continues its market share gains with a 3 percent growth in sales.
More articles on devices and implants:
Globus Medical expands portfolio with 2 new devices
Industry payments to physicians, hospitals drop 4.7% in 2017: 5 things to know
SeaSpine snags former NuVasive VP as new spinal systems executive: 5 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
